Category:
Description:
Indications:
Contraindications:
-
Pregnancy
and lactation
-
Undiagnosed
abnormal vaginal bleeding
-
Known
or suspected benign or malignant liver tumors while on oral
contraceptive use
- Breast carcinoma or estrogen-dependent neoplasia
-
Current
or history of thromboembolic disorders, cerebral vascular or
cardiovascular disease.
Precautions:
-
Pregnancy
category X
-
Take
as directed at intervals not exceeding 24 hours. Efficiency is dependent upon strict compliance.
-
Breakthrough
bleeding (“spotting”) may occur during initiation of therapy.
-
Instructions
for missed doses:
-
One
missed dose: Take as soon as possible or two tablets the next day
and continue
-
Two
missed doses: Take two tablets daily for two days, then continue
normal schedule
-
Three
missed doses: Discontinue therapy and begin new packet 7 days
following last dose
-
May
cause mental depression, fluid retention and depressed folate levels
-
Twenty-eight
day packs contain seven days of inert ingredients to maintain regimen
-
Begin
therapy on the fifth day of the cycle. Day one of cycle is the first day of menstrual bleeding.
Adverse
Reactions (Side Effects):
-
Abdominal
cramping, anorexia, nausea, vomiting
-
Acne
-
Edema,
weight gain
-
Unusual
tiredness or weakness
-
Cardiovascular
disorders (hypertension)
-
Thromboembolic
disorders
|
Dosage:
Administered
orally
|
The information contained here is an abbreviated summary. For more detailed
and complete information, consult the manufacturer's product information sheets
or standard textbooks.
Source:
Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department
of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300
OB-GYN 101:
Introductory Obstetrics & Gynecology
© 2003, 2004, 2005, 2008
Brookside Associates, LLC
All rights reserved
|